Telomir Pharmaceuticals
TELO
#7950
Rank
C$0.25 B
Marketcap
$8.71
Share price
-5.87%
Change (1 day)
N/A
Change (1 year)

Revenue for Telomir Pharmaceuticals (TELO)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Telomir Pharmaceuticals from 2023 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A